An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty

Journal of Arthroplasty

Volumn 32, Issue 11, 2017, Pages 3445-3448

  Kearns, Sean M ^a   Kuhar, Hannah N ^a   Bohl, Daniel D ^a   Levine, Brett R ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

blood loss; fibrin sealant; total hip arthroplasty; tranexamic acid; transfusion

Indexed keywords

APROTININ; FIBRIN GLUE; HEMOGLOBIN; ANTIFIBRINOLYTIC AGENT; DEOXYHEMOGLOBIN; HEMOSTATIC AGENT; TRANEXAMIC ACID;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; HIP REPLACEMENT; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; POSTOPERATIVE PERIOD;

ADMINISTRATION, INTRAVENOUS; ANTIFIBRINOLYTIC AGENTS; APROTININ; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; FIBRIN TISSUE ADHESIVE; HEMOGLOBINS; HEMOSTATICS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 85021113479     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2017.05.040     Document Type: Article

References (25)

1. Alshryda, S., Mason, J., Sarda, P., Nargol, A., Cooke, N., Ahmad, H., et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am 95 (2013), 1969–1974.
2. Martin, J.G., Cassatt, K.B., Kincaid-Cinnamon, K.A., Westendorf, D.S., Garton, A.S., Lemke, J.H., Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty 29 (2014), 889–894.
3. Harris, R.N., Moskal, J.T., Capps, S.G., Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. J Arthroplasty 30 (2015), 192–195.
4. Hsu, C.H., Lin, P.C., Kuo, F.C., Wang, J.W., A regime of two intravenous injections of tranexamic acid reduces blood loss in minimally invasive total hip arthroplasty: a prospective randomised double-blind study. Bone Joint J 97-B (2015), 905–910.
5. Wei, W., Wei, B., Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty 29 (2014), 2113–2116.
6. Wind, T.C., Barfield, W.R., Moskal, J.T., The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty 29 (2014), 387–389.
7. Yue, C., Kang, P., Yang, P., Xie, J., Pei, F., Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty 29 (2014), 2452–2456.
8. Sabatini, L., Trecci, A., Imarisio, D., Uslenghi, M.D., Bianco, G., Scagnelli, R., Fibrin tissue adhesive reduces postoperative blood loss in total knee arthroplasty. J Orthop Traumatol 13 (2012), 145–151.
9. Levy, O., Martinowitz, U., Oran, A., Tauber, C., Horoszowski, H., The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 81 (1999), 1580–1588.
10. Kluba, T., Fiedler, K., Kunze, B., Ipach, I., Suckel, A., Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL(R) in total knee arthroplasty. Arch Orthop Trauma Surg 132 (2012), 1147–1152.
11. Massin, P., Scemama, C., Jeanrot, C., Boyer, P., Does fibrin sealant use in total knee replacement reduce transfusion rates? A non-randomised comparative study. Orthop Traumatol Surg Res 98 (2012), 180–185.
12. Randelli, F., D'Anchise, R., Ragone, V., Serrao, L., Cabitza, P., Randelli, P., Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study. J Arthroplasty 29 (2014), 1516–1520.
13. Maheshwari, A.V., Korshunov, Y., Naziri, Q., Pivec, R., Mont, M.A., Rasquinha, V.J., No additional benefit with use of a fibrin sealant to decrease peri-operative blood loss during primary total knee arthroplasty. J Arthroplasty 29 (2014), 2109–2112.
14. Hebert, P.C., Wells, G., Blajchman, M.A., Marshall, J., Martin, C., Pagliarello, G., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med 340 (1999), 409–417.
15. Nishihara, S., Hamada, M., Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis?. Bone Joint J 97-B (2015), 458–462.
16. Levine, B.R., Haughom, B.D., Belkin, M.N., Goldstein, Z.H., Weighted versus uniform dose of tranexamic acid in patients undergoing primary, elective knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 29:9 Suppl (2014), 186–188.
17. North, W.T., Mehran, N., Davis, J.J., Silverton, C.D., Weir, R.M., Laker, M.W., Topical vs intravenous tranexamic acid in primary total hip arthroplasty: a double-blind, randomized controlled trial. J Arthroplasty 31 (2016), 1022–1026.
18. Chen, Y., Chen, Z., Cui, S., Li, Z., Yuan, Z., Topical versus systemic tranexamic acid after total knee and hip arthroplasty: a meta-analysis of randomized controlled trials. Medicine (Baltimore), 95, 2016, e4656.
19. Aguilera, X., Martinez-Zapata, M.J., Bosch, A., Urrútia, G., González, J.C., Jordan, M., et al. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. J Bone Joint Surg Am 95 (2013), 2001–2007.
20. Notarnicola, A., Moretti, L., Martucci, A., Spinarelli, A., Tafuri, S., Pesce, V., et al. Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty. Blood Coagul Fibrinolysis 23 (2012), 278–284.
21. McConnell, J.S., Shewale, S., Munro, N.A., Shah, K., Deakin, A.H., Kinninmonth, A.W., Reducing blood loss in primary knee arthroplasty: a prospective randomised controlled trial of tranexamic acid and fibrin spray. Knee 19 (2012), 295–298.
22. Kokoszka, A., Kuflik, P., Bitan, F., Casden, A., Neuwirth, M., Evidence-based review of the role of aprotinin in blood conservation during orthopaedic surgery. J Bone Joint Surg Am 87 (2005), 1129–1136.
23. Petsatodis, G., Samoladas, E., Christodoulou, A., Hatzokos, I., Pournaras, I., Does aprotinin reduce blood loss in total hip arthroplasty?. Orthopedics 29 (2006), 75–77.
24. Gill, J.B., Rosenstein, A., The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis. J Arthroplasty 21 (2006), 869–873.
25. Parker, M.J., Roberts, C.P., Hay, D., Closed suction drainage for hip and knee arthroplasty. A meta-analysis. J Bone Joint Surg Am 86-A (2004), 1146–1152.